How Important Is Controlling Risk Factors for the Prevention of a Stroke?

How Important Is Controlling Risk Factors for the Prevention of a Stroke?There has been a recent decline of about 20% to 40% in the incidence of cerebrovascular accidents (stroke). Although this is attributed to the improvement of risk factor control, the reason behind it is not utterly clear. This study estimated the impact of modifiable cardiovascular risk factors on the incidence of stroke between 1995 and 2012.

 

The risk of ischemic stroke was estimated by proportional regression among 26,329 participants in the register. The estimate was adjusted for unmodifiable risk factors such as age and gender.

 

There were 1226 new stroke cases per 36,7636 person-years of follow-up. Changes in risk factors accounted for 57% of the decrease in the incidence of this event from 1995 to 2012. The two factors that contributed the most to incidence decrease were systolic blood pressure (decreased by 26%) and smoking prevalence (decreased by 17%). Conversely, increasing diabetes prevalence contributed negatively to stroke incidence.

 

Conclusion

Changes in cardiovascular risk factors accounted for 57% of the decrease in stroke incidence. Reduction in systolic blood pressure and prevalence of smoking were the most important contributors.

 

Original title: Declining Incidence of Ischemic Stroke. What Is the Impact of Changing Risk Factors? The Tromso Study 1995 to 2012.

Reference: Anne M. Vangen-Lonne et al. Stroke. 2017 Feb 10. [Epub ahead of print].


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...